Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson's disease.
Ting ShenYumei YueFang BaTinging HeXiaocui TangXingyue HuJiali PuCong HuangWen LvBao-Rong ZhangHsin-Yi LaiPublished in: NPJ Parkinson's disease (2022)
The brain glymphatic system is involved in the clearance of misfolding α-synuclein, the impaired glymphatic system may contribute to the progression of Parkinson's disease (PD). We aimed to analyze the diffusion tensor image along the perivascular space (DTI-ALPS) and perivascular space (PVS) burden to reveal the relationship between the glymphatic system and PD. A cross-sectional study using a 7 T MRI of 76 PD patients and 48 controls was performed to evaluate the brain's glymphatic system. The DTI-ALPS and PVS burden in basal ganglia were calculated. Correlation analyses were conducted between DTI-ALPS, PVS burden and clinical features. We detected lower DTI-ALPS in the PD subgroup relative to controls, and the differences were more pronounced in patients with Hoehn & Yahr stage greater than two. The decreased DTI-ALPS was only evident in the left hemisphere in patients in the early stage but involved both hemispheres in more advanced PD patients. Decreased DTI-ALPS were also correlated with longer disease duration, higher Unified Parkinson's Disease Rating Scale motor score (UPDRS III) and UPDRS total scores, as well as higher levodopa equivalent daily dose. Moreover, the decreased DTI-ALPS correlated with increased PVS burden, and both indexes correlated with PD disease severity. This study demonstrated decreased DTI-ALPS in PD, which might initiate from the left hemisphere and progressively involve right hemisphere with the disease progression. Decreased DTI-ALPS index correlated with increased PVS burden, indicating that both metrics could provide supporting evidence of an impaired glymphatic system. MRI evaluation of the PVS burden and diffusion along PVS are potential imaging biomarkers for PD for disease progression.
Keyphrases
- white matter
- end stage renal disease
- early stage
- ejection fraction
- newly diagnosed
- prognostic factors
- magnetic resonance imaging
- peritoneal dialysis
- risk factors
- multiple sclerosis
- clinical trial
- squamous cell carcinoma
- high resolution
- genome wide
- patient reported outcomes
- lymph node
- parkinson disease
- risk assessment
- resting state
- diffusion weighted imaging
- functional connectivity
- patient reported
- fluorescence imaging